Literature DB >> 7195482

Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism.

E Melamed, F Hefti, D J Pettibone, J Liebman, R J Wurtman.   

Abstract

We studied the distribution of aromatic L-amino acid decarboxylase (AAAD) activity in striatal compartments of rats. After near-total destruction of nigrostriatal dopaminergic neurons, 15 to 20% of the initial enzyme activity remained. Striatal enzyme activity remained unchanged after destruction of serotoninergic terminals by electrolytic raphe lesions. Combined raphe-nigrostriatal lesions or nigrostriatal lesions alone produced similar decreases in striatal decarboxylase. Intrastriatal injection of kainic acid (which selectively destroys striatal interneurons and efferent neurons and also induces marked glial proliferation) reduced activity by 20%. Only 7% of initial striatal activity (perhaps localized in capillaries) remained after combined nigrostriatal-kainic acid lesions. These findings indicate that after degeneration of dopaminergic terminals, striatal interneurons and efferent neurons, but not serotonergic terminals of glia, contain an important fraction of the residual AAAD. This compartment may be the site of enzymatic conversion of exogenous L-dopa to dopamine in the parkinsonian striatum.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195482     DOI: 10.1212/wnl.31.6.651

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson's disease.

Authors:  Thomas Müller; Siegfried Muhlack
Journal:  J Neural Transm (Vienna)       Date:  2008-03-12       Impact factor: 3.575

2.  IPX066: a new intermediate-and extended-release carbidopa-levodopa formulation.

Authors:  Talene A Yacoubian
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

3.  Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Authors:  Torun Malmlöf; Kristin Feltmann; Åsa Konradsson-Geuken; Frank Schneider; Rudolf-Giesbert Alken; Torgny H Svensson; Björn Schilström
Journal:  J Neural Transm (Vienna)       Date:  2014-06-07       Impact factor: 3.575

4.  Acute levodopa administration reduces cortisol release in patients with Parkinson's disease.

Authors:  T Müller; J Welnic; S Muhlack
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

5.  Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease.

Authors:  R J Mandel; K G Rendahl; S K Spratt; R O Snyder; L K Cohen; S E Leff
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

6.  Selective inhibition of monoamine oxidase type B by MDL 72145 increases the central effects of L-dopa without modifying its cardiovascular effects.

Authors:  J R Fozard; M G Palfreyman; M Robin; M Zreika
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

7.  Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease.

Authors:  P A Kempster; J P Frankel; M Bovingdon; R Webster; A J Lees; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 8.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

9.  Brain kinetics of L-[beta-11C]dopa in humans studied by positron emission tomography.

Authors:  P Hartvig; H Agren; L Reibring; J Tedroff; P Bjurling; T Kihlberg; B Långström
Journal:  J Neural Transm Gen Sect       Date:  1991

10.  Understanding and prevention of "therapy-" induced dyskinesias.

Authors:  Iciar Aviles-Olmos; Zinovia Kefalopoulou; Thomas Foltynie
Journal:  Parkinsons Dis       Date:  2012-05-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.